Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Eur J Pharm Biopharm. 2017 Jan 25;114:108–118. doi: 10.1016/j.ejpb.2017.01.011

Figure 11.

Figure 11

Knockdown of P-gp in 4T1-R (top panel), SKBR-3 (middle panel) and MCF-7 (bottom panel) breast cancer cells with/without aptamer-labeled F31 nanoparticles compared to lipofectamine transfection. In both cases of lipofectamine and aptamer-labeled nanoparticle transfection, the cells were transfected with 100 pmol siRNA for 24h, and then the cells were scraped by using trypsin-EDTA, washed with PBS, pelleted and the expression of P-gp was measured by Western blot analysis.